Anti-EGFR–mediated radiosensitization as a result of augmented EGFR expression
- 30 June 2004
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 59 (2), S2-S10
- https://doi.org/10.1016/j.ijrobp.2004.01.053
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Treatment of pancreatic cancer xenografts with Erbitux (IMC-C225) anti-EGFR antibody, gemcitabine, and radiationInternational Journal of Radiation Oncology*Biology*Physics, 2002
- Epidermal growth factor receptor as a therapeutic target in head and neck cancerSeminars in Radiation Oncology, 2002
- C225 antiepidermal growth factor receptor antibody enhances tumor radiocurabilityInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Epidermal Growth Factor Receptor Signaling and the Invasive Phenotype of Ovarian Carcinoma CellsJNCI Journal of the National Cancer Institute, 2001
- Phase I Studies of Anti–Epidermal Growth Factor Receptor Chimeric Antibody C225 Alone and in Combination With CisplatinJournal of Clinical Oncology, 2000
- STAT3 mediates the survival signal in oncogenicras-transfected intestinal epithelial cellsInternational Journal of Cancer, 1998
- Levels of TGF-α and EGFR Protein in Head and Neck Squamous Cell Carcinoma and Patient SurvivalJNCI Journal of the National Cancer Institute, 1998
- Epidermal growth factor receptor (EGFR) is not related to the prognosis of cervical cancerCancer Letters, 1998
- Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer.Journal of Clinical Oncology, 1993
- Growth Factors and CancerScience, 1991